Sun B - Search Results

1

Preclinical Development of New Therapy for Glycogen Storage Diseases.

Sun B, Brooks ED, Koeberl DD. Sun B, et al. Curr Gene Ther. 2015;15(4):338-47. doi: 10.2174/1566523215666150630132253. Curr Gene Ther. 2015. PMID: 26122079 Free PMC article. Review.

2

Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector.

Sun BD, Chen YT, Bird A, Amalfitano A, Koeberl DD. Sun BD, et al. Mol Ther. 2003 Feb;7(2):193-201. doi: 10.1016/s1525-0016(02)00055-2. Mol Ther. 2003. PMID: 12597907 Free article.

3

Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vector.

Sun B, Chen YT, Bird A, Xu F, Hou YX, Amalfitano A, Koeberl DD. Sun B, et al. Mol Ther. 2003 Apr;7(4):467-77. doi: 10.1016/s1525-0016(03)00022-4. Mol Ther. 2003. PMID: 12727109 Free article.

4

Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.

Sun B, Zhang H, Franco LM, Young SP, Schneider A, Bird A, Amalfitano A, Chen YT, Koeberl DD. Sun B, et al. Mol Ther. 2005 Jan;11(1):57-65. doi: 10.1016/j.ymthe.2004.10.004. Mol Ther. 2005. PMID: 15585406 Free article.

5

Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter.

Sun B, Zhang H, Franco LM, Brown T, Bird A, Schneider A, Koeberl DD. Sun B, et al. Mol Ther. 2005 Jun;11(6):889-98. doi: 10.1016/j.ymthe.2005.01.012. Mol Ther. 2005. PMID: 15922959 Free article.

6

Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II.

Franco LM, Sun B, Yang X, Bird A, Zhang H, Schneider A, Brown T, Young SP, Clay TM, Amalfitano A, Chen YT, Koeberl DD. Franco LM, et al. Among authors: sun b. Mol Ther. 2005 Nov;12(5):876-84. doi: 10.1016/j.ymthe.2005.04.024. Epub 2005 Jul 6. Mol Ther. 2005. PMID: 16005263 Free article.

7

Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.

Koeberl DD, Sun BD, Damodaran TV, Brown T, Millington DS, Benjamin DK Jr, Bird A, Schneider A, Hillman S, Jackson M, Beaty RM, Chen YT. Koeberl DD, et al. Among authors: sun bd. Gene Ther. 2006 Sep;13(17):1281-9. doi: 10.1038/sj.gt.3302774. Epub 2006 May 4. Gene Ther. 2006. PMID: 16672983

8

Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II.

Sun B, Zhang H, Benjamin DK Jr, Brown T, Bird A, Young SP, McVie-Wylie A, Chen YT, Koeberl DD. Sun B, et al. Mol Ther. 2006 Dec;14(6):822-30. doi: 10.1016/j.ymthe.2006.08.001. Epub 2006 Sep 20. Mol Ther. 2006. PMID: 16987711 Free PMC article.

9

Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia.

Koeberl DD, Sun B, Bird A, Chen YT, Oka K, Chan L. Koeberl DD, et al. Among authors: sun b. Mol Ther. 2007 Jul;15(7):1253-8. doi: 10.1038/sj.mt.6300188. Epub 2007 May 15. Mol Ther. 2007. PMID: 17505475 Free article.

10

Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance.

Sun B, Bird A, Young SP, Kishnani PS, Chen YT, Koeberl DD. Sun B, et al. Am J Hum Genet. 2007 Nov;81(5):1042-9. doi: 10.1086/522236. Epub 2007 Sep 21. Am J Hum Genet. 2007. PMID: 17924344 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,409 results

Search Page

Filters